Prevalensi ameloblastoma berdasarkan usia, jenis kelamin, dan penatalaksanaannya di RS POLRI Sukanto Jakarta periode 2007-2013 (Laporan Penelitian)
A meloblastoma adalah tumor odontogenik epitelium, bersifat jinak dan berasal dari sel epitel ectodermal. Persentase ameloblastoma dari seluruh tumor rongga mulut adalah 1% dan persentase ameloblastoma dari seluruh tumor odontogenik 11 %. Penelitian mengenai frekuensi dan distribusi ameloblastoma berdasarkan usia, jenis kelamin dan penatalkasnaannya pernah dilakukan di beberapa negara dengan hasil yang berbeda. Penelitian dilakukan menggunakan metode survei deskriptif terhadap 21 data sukunder dari rekam medis di RS POLRI Jakarta. Berdasarkan hasil : didapatkan jarak usia pasien ameloblastoma adalah 5-77 tahun dengan kelompok usia yang memiliki insidensi tertinggi adalah kelompok usia A (1-30 tahun) atau usia dekade kedua (53,2 %) Usia rata-ratanya adalah 29 tahun. Ada perbedaan distribusi penyakit antara wanita (52%) laki (48% ). Namun tidak signifikan.
A meloblastoma is a benign and locally invasive neoplasm. Ameloblastoma percentage of all oral tumors is 1% and ameloblastoma of all odontogenic tumord is 11% . some research about ameloblastoma prevalence by age, gender, and treatment has been done in saveral contries with diffrence result in each countries. Aim:To know about ameloblastoma frequnency and distribution based on age group, gender and therapy. material and metod: The research was done with descriptive survey method to 21 ameloblastoma cases at Sukanto Police Hospital, East Jakarta, Indonesia from 2007-to 2013. Results: Based on research, the age-range for ameloblastoma patients were 5-77 years with incidence occured in age-group was group A (1-30 years) or in the scond decade (53,2%). Average age was 29 years. Conclusion: there was a diffrence in frequency and distribution of ameloblastoma certain age group. there was a slight diference in frequency and distribution towards gender but it was not significantly . Hemimandibulectomy was the often done treatment.